ID

18291

Descripción

Phase II High-Dose Cyclophosphamide for Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00296205

Link

https://clinicaltrials.gov/show/NCT00296205

Palabras clave

Versiones (1)
  1. 28/10/16 28/10/16 -
Subido en

28 de octubre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Multiple Sclerosis NCT00296205

Inglés

Eligibility Multiple Sclerosis NCT00296205

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of secondary progressive (spms), primary progressive (ppms) or progressive relapsing (prms) multiple sclerosis
Descripción

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Progressive Relapsing

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0751965
UMLS CUI [2]
C0751964
UMLS CUI [3]
C0393666
a diagnosis of ms will be established by fulfilling criteria "recommended diagnostic criteria for multiple sclerosis: guidelines from the internal panel on the diagnosis of multiple sclerosis"
Descripción

Multiple Sclerosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026769
the subtype of ms will be established by the natural history of the disease
Descripción

Multiple Sclerosis Subtype | natural history of disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0449560
UMLS CUI [2]
C0599879
age >18 but < 75 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
an extended disability status scale (edss) score of >3.5 after two standard treatment regimens ifnb1a ifnb1b glatiramer acetate mitoxanthrone steroids, plasmapheresis or ivig individually or in combination constitute a single treatment regimen
Descripción

EDSS | Standard of Care Quantity | Interferon beta-1a | interferon beta-1b | glatiramer acetate | Mitoxantrone | Plasmapheresis | Immunoglobulins, Intravenous

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0451246
UMLS CUI [2,1]
C2936643
UMLS CUI [2,2]
C1265611
UMLS CUI [3]
C0254119
UMLS CUI [4]
C0244713
UMLS CUI [5]
C0289884
UMLS CUI [6]
C0026259
UMLS CUI [7]
C0032134
UMLS CUI [8]
C0085297
patient must have a left ventricular ejection fraction of > 45%
Descripción

Left ventricular ejection fraction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428772
serum creatinine <3mg/dl
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
for women of childbearing potential, serum βhcg (less than seven days before start of cyclophosphamide)
Descripción

Childbearing Potential Serum Beta-HCG Test | Cyclophosphamide

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C1255526
UMLS CUI [2]
C0010583
willingness to participate in a clinical trial
Descripción

Study Subject Participation Status Willing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0600109
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who are preterminal or moribund
Descripción

pre-terminal | Moribund

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0184771
UMLS CUI [2]
C0424547
patients with active malignancies
Descripción

Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
patients with chromosomal abnormalities or peripheral blood counts suggestive of myelodysplastic syndrome
Descripción

Chromosome Aberrations | Peripheral blood Cell Count Suggestive of MYELODYSPLASTIC SYNDROME

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0008625
UMLS CUI [2,1]
C0229664
UMLS CUI [2,2]
C0005771
UMLS CUI [2,3]
C0332299
UMLS CUI [2,4]
C3463824
patients with active bacterial or fungal infections requiring oral or intravenous antimicrobials are not eligible until resolution of the infection
Descripción

Bacterial Infections Requirement Microbicides Oral | Mycoses Requirement Microbicides Oral | Bacterial Infections Requirement Intravenous injection of antimicrobial substance | Mycoses Requirement Intravenous injection of antimicrobial substance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004623
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C1136254
UMLS CUI [1,4]
C1527415
UMLS CUI [2,1]
C0026946
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C1136254
UMLS CUI [2,4]
C1527415
UMLS CUI [3,1]
C0004623
UMLS CUI [3,2]
C1514873
UMLS CUI [3,3]
C1960380
UMLS CUI [4,1]
C0026946
UMLS CUI [4,2]
C1514873
UMLS CUI [4,3]
C1960380
pregnant women and breast-feeding women
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients with known intolerance to g-csf
Descripción

intolerance to G-CSF

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0079459
Volver a la parte superior de la página

Similar models

Eligibility Multiple Sclerosis NCT00296205

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Progressive Relapsing
Item
diagnosis of secondary progressive (spms), primary progressive (ppms) or progressive relapsing (prms) multiple sclerosis
boolean
C0751965 (UMLS CUI [1])
C0751964 (UMLS CUI [2])
C0393666 (UMLS CUI [3])
Multiple Sclerosis
Item
a diagnosis of ms will be established by fulfilling criteria "recommended diagnostic criteria for multiple sclerosis: guidelines from the internal panel on the diagnosis of multiple sclerosis"
boolean
C0026769 (UMLS CUI [1])
Multiple Sclerosis Subtype | natural history of disease
Item
the subtype of ms will be established by the natural history of the disease
boolean
C0026769 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
C0599879 (UMLS CUI [2])
Age
Item
age >18 but < 75 years
boolean
C0001779 (UMLS CUI [1])
EDSS | Standard of Care Quantity | Interferon beta-1a | interferon beta-1b | glatiramer acetate | Mitoxantrone | Plasmapheresis | Immunoglobulins, Intravenous
Item
an extended disability status scale (edss) score of >3.5 after two standard treatment regimens ifnb1a ifnb1b glatiramer acetate mitoxanthrone steroids, plasmapheresis or ivig individually or in combination constitute a single treatment regimen
boolean
C0451246 (UMLS CUI [1])
C2936643 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0254119 (UMLS CUI [3])
C0244713 (UMLS CUI [4])
C0289884 (UMLS CUI [5])
C0026259 (UMLS CUI [6])
C0032134 (UMLS CUI [7])
C0085297 (UMLS CUI [8])
Left ventricular ejection fraction
Item
patient must have a left ventricular ejection fraction of > 45%
boolean
C0428772 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine <3mg/dl
boolean
C0201976 (UMLS CUI [1])
Childbearing Potential Serum Beta-HCG Test | Cyclophosphamide
Item
for women of childbearing potential, serum βhcg (less than seven days before start of cyclophosphamide)
boolean
C3831118 (UMLS CUI [1,1])
C1255526 (UMLS CUI [1,2])
C0010583 (UMLS CUI [2])
Study Subject Participation Status Willing
Item
willingness to participate in a clinical trial
boolean
C2348568 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
pre-terminal | Moribund
Item
patients who are preterminal or moribund
boolean
C0184771 (UMLS CUI [1])
C0424547 (UMLS CUI [2])
Malignant Neoplasms
Item
patients with active malignancies
boolean
C0006826 (UMLS CUI [1])
Chromosome Aberrations | Peripheral blood Cell Count Suggestive of MYELODYSPLASTIC SYNDROME
Item
patients with chromosomal abnormalities or peripheral blood counts suggestive of myelodysplastic syndrome
boolean
C0008625 (UMLS CUI [1])
C0229664 (UMLS CUI [2,1])
C0005771 (UMLS CUI [2,2])
C0332299 (UMLS CUI [2,3])
C3463824 (UMLS CUI [2,4])
Bacterial Infections Requirement Microbicides Oral | Mycoses Requirement Microbicides Oral | Bacterial Infections Requirement Intravenous injection of antimicrobial substance | Mycoses Requirement Intravenous injection of antimicrobial substance
Item
patients with active bacterial or fungal infections requiring oral or intravenous antimicrobials are not eligible until resolution of the infection
boolean
C0004623 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1136254 (UMLS CUI [1,3])
C1527415 (UMLS CUI [1,4])
C0026946 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C1136254 (UMLS CUI [2,3])
C1527415 (UMLS CUI [2,4])
C0004623 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C1960380 (UMLS CUI [3,3])
C0026946 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
C1960380 (UMLS CUI [4,3])
Pregnancy | Breast Feeding
Item
pregnant women and breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
intolerance to G-CSF
Item
patients with known intolerance to g-csf
boolean
C1744706 (UMLS CUI [1,1])
C0079459 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial